Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
archive
articles containing video clips
cancer
cannabis
certification marks
colloids
consumer organizations
coronavirus
dosage forms
drug delivery devices
european economic area
fda
gels
government
health
histopathology
infectious causes of cancer
male genital neoplasia
marijuana
medical
medical marijuana
medical trial
medicine
neoplastic and hyperplastic prostate disorders
news
physical chemistry
prostate cancer
rtt
skin cancer
tc
usa
What
release
9
×
treatment
9
×
press
announced
company
medical
today
announces
cancer
radiotherapy
received
technology
absorbable
according
augmenix
chemical
develops
drug
function
home
hydrogel
hydrogels
manufactures
novel
organs
patients
phase
proprietary
prostate
protect
risk
sells
separate
skin
treat
trial
use
agency
allowance
allows
Language
unset
Current search:
release
×
treatment
×
@bgr.com
1 year ago
Trial begins for radioactive gel that painlessly kills skin cancer in seconds
@slashgear.com
3 years ago
Pfizer may release an at-home COVID-19 treatment before the holidays
@techcrunch.com
5 years ago
With CBD, marijuana-based medicine gets its first greenlight from the FDA
@venturebeat.com
6 years ago
CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device to Support Heart Function
@venturebeat.com
6 years ago
Clarify Medical and DermatologistOnCall Announce a Partnership to Innovate the Treatment of Chronic Skin Conditions
@venturebeat.com
6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com
7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com
7 years ago
Svelte Medical Systems Announces CE Mark Certification of DIRECT RX™
@venturebeat.com
8 years ago
Newron Receives Positive Opinion for Orphan Medicinal Product Designation for Sarizotan to Treat Patients with Rett Syndrome from the Committee for Orphan Medicinal Products from the European Medicines Agency